We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
19 hedge funds and large institutions have $51M invested in Rocket Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
27% more funds holding
Funds holding: 15 → 19 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
3% less capital invested
Capital invested by funds: $52.5M → $51M (-$1.45M)
Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
5
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jennison Associates
New York
|
+$2.62M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$1.04M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$483K |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$387K |
| 5 |
TI
Telemetry Investments
New York
|
+$298K |
Top Sellers
| 1 |
SIM
Spark Investment Management
New York
|
-$533K |
| 2 |
PVI
Pura Vida Investments
New York
|
-$474K |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$111K |
| 4 |
Morgan Stanley
New York
|
-$94.4K |
| 5 |
Citigroup
New York
|
-$17.7K |
